SARS-CoV-2 virus utilizes the same cellular receptor as SARS-CoV-1, ACE2, for mediating human infection but has exhibited a distinctive infectivity and transmissibility profile since it was first recognized in humans in Wuhan, China, in December 20196. This evidence concerns the gene ACE2 and infection.